AI-Powered Vaccine Shrinks Tumors in Dog with Aggressive Cancer, Offering Hope for Personalized Cancer Therapies
A Sydney entrepreneur’s determination to save his beloved dog, Rosie, has led to a remarkable breakthrough in personalized cancer treatment. After conventional therapies failed, Paul Conyngham harnessed the power of artificial intelligence and genomic sequencing to develop a custom mRNA vaccine that has significantly shrunk Rosie’s tumors.
A Desperate Search for a Cure
In 2024, Paul Conyngham received the devastating diagnosis that his rescue dog, Rosie, a staffy-cross-shar pei, had aggressive mast cell cancer. Despite undergoing surgery, chemotherapy, and immunotherapy, Rosie’s condition continued to deteriorate. Veterinarians estimated she had only a few months to live. Determined to find a solution, Conyngham, an AI consultant and entrepreneur, turned to cutting-edge technology.
Unlocking the Genetic Code with AI
Conyngham collaborated with the Ramaciotti Centre for Genomics at the University of New South Wales (UNSW). He paid $3,000 for Rosie’s genomic sequencing, a process that maps the tumor’s DNA to identify the mutations driving its growth. “DNA sequencing helps map the tumor and identify the mutations that drive the disease,” explained Associate Professor Martin Smith of UNSW.
Conyngham then utilized his expertise in machine learning and data analysis, along with tools like ChatGPT and AlphaFold, to analyze the complex genetic data. He identified mutated proteins – neoantigens – that could be targeted by a personalized therapy.
The World’s First Personalized mRNA Cancer Vaccine for a Dog
After identifying potential therapeutic targets, Conyngham faced a roadblock when a promising immunotherapy drug was unavailable. This led to the development of a bespoke mRNA vaccine, designed by Professor Pall Thordarson, director of the UNSW RNA Institute, using Conyngham’s data and code. “This is the first time a personalized cancer vaccine has been developed for a dog,” Thordarson stated.
mRNA technology works by providing cells with instructions to create proteins that are unique to the tumor. The body then recognizes these proteins as foreign and mounts an immune response, specifically targeting the cancer cells.
Remarkable Results and a Hopeful Future
The vaccine was administered near Rosie’s tumors over the Christmas period. Within weeks, a tumor approximately the size of a tennis ball shrank by about half, and other tumors as well decreased in size. Rosie’s energy levels improved dramatically, and she began chasing rabbits again.
Veterinary Professor Rachel Allavena from the University of Queensland confirmed the positive results, stating, “It definitely works.”
Whereas the treatment isn’t a complete cure, it offers a significant improvement in Rosie’s quality of life and demonstrates the potential of AI-driven personalized cancer therapies. Thordarson emphasized the speed and adaptability of mRNA technology, stating, “It’s like a digital drug. You change the information, not the chemistry.”
This case highlights the growing promise of personalized medicine and the potential for AI to revolutionize cancer treatment for both animals and humans.